Cite Filings / IMVT / 0001764013-26-000093

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Immunovant, Inc. Filed 2026-07-22 Acc 0001764013-26-000093

Documents 1

DEFA14A Proxy Materials , defa14aadditionalmaterials.htm

Around this filing

2026-07-24 4 Chief Technology Officer sold 2,857 shares at $38.69 ($110,537)
2026-07-24 4 Director sold 1,500 shares at $39.80 ($59,700)
2026-07-24 4 Chief Financial Officer sold 6,798 shares at $38.69 ($263,015)
2026-07-22 ARS Annual Report to Security Holders
2026-07-22 DEFA14A Proxy Materials
2026-07-22 DEF 14A Proxy Statement
2025-07-09 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading defa14aadditionalmaterials.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…